Tuatara Capital

Tuatara Capital, L.P. is a private equity firm established in 2014 and headquartered in New York. The firm specializes in growth equity, buyouts, and late-stage venture investments within the legal cannabis industry in the United States. Tuatara Capital focuses on companies that operate in compliance with U.S. Department of Justice guidelines and seeks to invest across the entire cannabis supply chain, including areas such as cultivation, processing, retail, technology, and industrial services. The firm aims to acquire both minority and majority stakes in market-leading companies that are pivotal in advancing the legal cannabis sector.

Ivan Botev

Vice President - Investments

Jeffrey Cui

Associate - Investments

Adrienne Foo

Managing Director, Finance

AL Foreman

Co-Founder, Partner & Chief Investment Officer

Albert J. Foreman

Partner and CIO

Mark McGrath

Associate, Investor Relations

Justin Pertile

Associate - Investments

Marc Riiska

Partner, COO

Sergey Sherman

Managing Director, Investments

Elazar Sigal

Associate, Investments

Young Yeo

Principal, Investments

Mark Zittman

Founding Partner & Senior Advisor

12 past transactions

springbig

Post in 2022
SpringBig, Inc. develops loyalty marketing and customer relationship management (CRM) software tailored for cannabis dispensaries and brands. Founded in 2012 and headquartered in Boca Raton, Florida, the company offers a platform designed to enhance customer retention, boost revenue, and cultivate brand loyalty through targeted marketing campaigns. This platform enables merchants to implement loyalty programs and rewards, manage referral initiatives, and conduct brand advertising, all accessible via an online portal and mobile applications. SpringBig's technology solutions are specifically crafted to meet the unique needs of retailers in the cannabis sector.

Hound Labs

Venture Round in 2021
Hound Labs, Inc. develops a handheld device that detects and measures the level of tetrahydrocannabinol in the breath. The company was founded in 2014 and is based in Oakland, California.

Willow Biosciences

Post in 2020
Willow Biosciences is a multidisciplinary team of discovery biologists, biochemists, and geneticists. It specializes in the fields of biotechnology and healthcare.

Demetrix

Series A in 2019
Demetrix, Inc. is a biotechnology company that specializes in manufacturing natural medicines through synthetic biology. Established in 2015 and headquartered in Emeryville, California, the company employs advanced genetics and computational technologies to develop innovative drugs. Demetrix focuses on refactoring microbial hosts for gene synthesis, allowing for the engineering of strains that produce co-evolved and bio-inspired medicines as well as nutraceuticals. Additionally, the company is involved in providing medicinal cannabinoid products tailored for the pharmaceutical, supplement, and consumer product sectors.

Green Flower

Series A in 2019
Green Flower Media, Inc. produces and publishes videos for cannabis experts, doctors, scientists, researchers, entrepreneurs, investors, and thought-leaders that give facts, science, and knowledge of cannabis and cannabis industry. The company publishes online courses, classes, videos, and articles about cannabis. The company was incorporated in 2015 and is based in Ventura, California.

Enlighten

Series B in 2019
Enlighten Technologies provides retail and marketing solutions through its platform. It offers content-driven television network broadcasting on television screens placed inside cannabis dispensaries. It also provides ecommerce, updating in menus online, and awareness about product services. The company was founded in 2010 and is based in Bowling Green, Kentucky.
Connecticut Pharmaceutical Solutions, LLC engages in the development of medical cannabis in Connecticut. The company’s product include CPS flower, CPS concentrates, CPS vape cartridges, CPS vape refills, CPS oil syringes, CPS tablets and capsules, CPS tinctures, CPS oral sprays, and CPS lotions. Connecticut Pharmaceutical Solutions, LLC was founded in 2013 and is headquartered in Portland, Connecticut.

Enlighten

Series A in 2018
Enlighten Technologies provides retail and marketing solutions through its platform. It offers content-driven television network broadcasting on television screens placed inside cannabis dispensaries. It also provides ecommerce, updating in menus online, and awareness about product services. The company was founded in 2010 and is based in Bowling Green, Kentucky.

Willie's Reserve

Convertible Note in 2018
Willie Nelson has never made any bones about it. The cannabis culture is a way of life for him. And he has always operated under a simple philosophy: my stash is your stash.

Green Dot Labs

Series A in 2017
Green Dot Labs committed to using the safest, most responsible extraction methods possible in their state-of-the-art laboratory. They respect the environment, their employees, and their consumers and they have gone to great lengths to ensure the wellbeing of all.

Teewinot Life Sciences

Series B in 2017
Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulation technology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines.

Teewinot Life Sciences

Series A in 2015
Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulation technology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.